Samantha Gaffney Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1633 Martin Luther King Jr Blvd, Houma, LA 70360 Phone: 985-851-3284 |
Dr. Celeste Shavon Mart, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1511 E Tunnel Blvd, Houma, LA 70363 Phone: 985-873-2937 |
Megan Luke, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1415 Saint Charles St, Houma, LA 70360 Phone: 985-868-4033 |
Jessica Morgan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7869 Main St, Houma, LA 70360 Phone: 985-873-8526 |
Jamie Roy-daigle, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8166 Main St, Houma, LA 70360 Phone: 985-873-4067 |
News Archive
A new computational model that simulates bone metastasis of prostate cancer has the potential to rapidly assess experimental therapy outcomes and help develop personalized medicine for patients with this disease, according to data published in Cancer Research, a journal of the American Association for Cancer Research.
Researchers from Case Western Reserve University School of Medicine and the Dana-Farber Cancer Institute have made a fundamental discovery relevant to the understanding and treatment of heart failure - a leading cause of death worldwide. The team discovered a new molecular pathway responsible for causing heart failure and showed that a first-in-class prototype drug, JQ1, blocks this pathway to protect the heart from damage.
Strains of genital herpes in Africa are far more virulent than those in the United States, researchers at Harvard Medical School report, a striking insight into a common disease with important implications for preventing HIV transmission in a region staggered by the HIV/AIDS epidemic.
Cells have two different programs to safeguard them from getting out of control and developing cancer. One of them is senescence (biological aging). It puts cancer cells into a permanent sleep so they no longer divide and grow in an uncontrolled way.
LensAR Inc., developer of the LensAR Laser System for cataract surgery, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the company's next-generation commercial system, for use in anterior capsulotomy, with and without laser phacofragmentation during cataract surgery.
› Verified 7 days ago